GP KFPs / SAQs · pregnancy-and-reproductive-health
Bleeding and pain in early pregnancy — KFP-style written assessment
KFP-style staged scenarios on early pregnancy bleeding: the discriminatory-zone PUL, methotrexate selection for ectopic, miscarriage management options with Cochrane numbers, molar red flags, anti-D and recurrent loss work-up.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
Locate, stage, choose — and follow to negative
KFP 1 (10 marks)
A 31-year-old woman presents with six weeks amenorrhoea and right iliac fossa discomfort. Urinary hCG positive; serum hCG 1400 IU/L. TVS: empty uterus, no adnexal mass, no free fluid. She is haemodynamically stable. [2]
- Label her situation using correct terminology. (2) [2]
- Outline the next 48 hours. (3) [2]
- Her repeat hCG rises to 2100 IU/L at 48 hours; rescan still shows empty uterus. What now? (3) [1]
- Which single factor most predicts failure of conservative management? (2) [2]
Model answers
- Pregnancy of unknown location (PUL) — a positive pregnancy test without ultrasound confirmation of location. [2]
- Serial hCG at 48 hours plus repeat transvaginal scan; safety-net for sudden pain, bleeding or shoulder tip; early pregnancy unit contact numbers. A viable intrauterine pregnancy usually shows roughly a doubling by 48 hours. [2]
- An empty uterus above the discriminatory zone (~1500–2000 IU/L) is treated as ectopic until proven otherwise — same-day gynaecology review for medical management criteria (methotrexate) if unruptured, stable, no cardiac activity, mass below 3.5 cm. [1][2]
- Initial serum beta-hCG level — in the placebo-controlled trial it was the only covariate significantly associated with outcome. [2]
References4ShowHide
- [1]Solangon SA, Van Wely M, Van Mello N, et al. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: an individual participant data meta-analysis Acta Obstet Gynecol Scand, 2023.PMID 37345445
- [2]Jurkovic D, Memtsa M, Sawyer E, et al. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled RCT Ultrasound Obstet Gynecol, 2017.PMID 27731538
- [3]Alur-Gupta S, Cooney LG, Senapati S, et al. Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis Am J Obstet Gynecol, 2019.PMID 30629908
- [4]Nanda K, Lopez LM, Grimes DA, et al. Expectant care versus surgical treatment for miscarriage Cochrane Database Syst Rev, 2012.PMID 22419288